Arteris (NASDAQ:AIP) Stock: Insider Paul Alpern Sells 6,003 Shares

Arteris, Inc. (NASDAQ:AIP) VP Paul Alpern sold 6,003 shares of the business’s stock in a transaction that occurred on Monday, October 5th. The shares were sold at an average price of $24.24, for a total transaction of $145,512.72. Following the completion of the sale, the vice president directly owned 61,082 shares in the company, valued at approximately $1,480,627.68. This trade represents a 8.95% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Arteris Stock Performance

Shares of AIP stock traded up $0.16 during trading on Tuesday, reaching $24.13. 476,272 shares of the company’s stock traded hands, compared to its average volume of 728,847. The firm’s 50-day moving average is $24.73 and its 200 day moving average is $28.61. The company has a market capitalization of $1.19 billion, a P/E ratio of -27.74 and a beta of 1.90. Arteris, Inc. has a 1 year low of $12.06 and a 1 year high of $50.26. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 0.03.

Arteris (NASDAQ:AIP) last released its quarterly earnings data on Thursday, August 6th. The company reported ($0.10) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.06). Arteris had a negative net margin of 46.70% and a negative return on equity of 295.96%. The business had revenue of $24.13 million during the quarter, compared to analysts’ expectations of $23.48 million. Equities research analysts expect that Arteris, Inc. will post -0.68 EPS for the current year.

Hedge Funds Weigh In On Arteris

A number of institutional investors have recently added to or reduced their stakes in AIP. Versant Capital Management Inc grew its holdings in Arteris by 33.7% in the second quarter. Versant Capital Management Inc now owns 1,150 shares of the company’s stock worth $56,000 after purchasing an additional 290 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new position in shares of Arteris during the second quarter valued at approximately $53,000. Allworth Financial LP bought a new stake in shares of Arteris in the 2nd quarter worth approximately $87,000. Wellington Management Group LLP boosted its position in shares of Arteris by 0.4% in the 2nd quarter. Wellington Management Group LLP now owns 500,200 shares of the company’s stock worth $24,305,000 after purchasing an additional 1,897 shares in the last quarter. Finally, Royal Bank of Canada grew its stake in shares of Arteris by 366.7% in the 1st quarter. Royal Bank of Canada now owns 4,023 shares of the company’s stock worth $66,000 after buying an additional 3,161 shares during the last quarter. 64.36% of the stock is currently owned by institutional investors.

Key Stories Impacting Arteris

Here are the key news stories impacting Arteris this week:

• Positive Sentiment: Arteris won an additional $3.3 million through the Trusted and Assured Microelectronics program to expand its third-party semiconductor IP security-assurance efforts. The company is collaborating with BAE Systems and SiFive, potentially strengthening its position in defense-related and trusted-chip supply chains. Arteris funding announcement
• Neutral Sentiment: CEO K. Charles Janac and Vice President Paul Alpern sold shares, but the filings state the transactions were made to cover tax withholding obligations related to vested equity awards. Because these were tax-related sales rather than clearly discretionary trades, they provide a limited signal about management’s outlook. SEC filing for executive share sales
• Negative Sentiment: Major shareholder Bayview Legacy LLC sold 100,000 shares for approximately $2.38 million, reducing its ownership by 1.22%. The filing did not cite tax withholding as the reason, so the sale could create modest supply pressure and raise concerns about near-term shareholder confidence. SEC filing for Bayview Legacy share sale

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the company. Craig Hallum initiated coverage on Arteris in a research note on Monday, September 21st. They set a “buy” rating and a $30.00 price objective on the stock. Rosenblatt Securities restated a “buy” rating and issued a $38.00 target price on shares of Arteris in a research note on Friday, August 7th. Jefferies Financial Group upgraded Arteris from a “hold” rating to a “buy” rating and upped their price target for the company from $35.00 to $50.00 in a research report on Friday, August 7th. Roth Capital initiated coverage on shares of Arteris in a report on Tuesday, August 4th. They issued a “buy” rating and a $40.00 price target on the stock. Finally, Oppenheimer started coverage on shares of Arteris in a report on Thursday, July 16th. They issued an “outperform” rating and a $40.00 price target on the stock. Six research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $39.43.

About Arteris

Arteris, Inc is a semiconductor intellectual property (IP) company that develops technologies used in the design of system-on-chip (SoC) devices. Its products help semiconductor and electronics companies connect, manage and protect the various processing, memory and other functional components integrated into complex chips.

The company’s portfolio includes network-on-chip (NoC) interconnect IP, which supports communication among different elements within an SoC, as well as cache-coherent interconnect, system IP and related design technologies.